Leading Neurolutions into Kandu
Petrossian led Neurolutions before becoming CEO of Kandu when Neurolutions merged with Kandu Health in April 2025.3,2
The merger combined IpsiHand BCI therapy with Kandu Health's remote stroke support services.2
IpsiHand commercialization
Under Petrossian's leadership IpsiHand remained the FDA-cleared noninvasive BCI flagship for chronic upper-limb stroke recovery.1,4
Kandu continues to publish clinical outcome claims and home-therapy positioning for survivors.1
Links
Sources
Photo: Kandu, Leo Petrossian.




